Senior Vice President, Clinical Development jobs in United States
cer-icon
Apply on Employer Site
company-logo

Immunovant · 2 weeks ago

Senior Vice President, Clinical Development

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. The Senior Vice President, Clinical Development will lead all development programs and provide medical oversight for clinical studies, ensuring timely execution of deliverables in collaboration with internal and external partners.

BiopharmaBiotechnologyPharmaceutical
Hiring Manager
Mohammad Ouranus
linkedin

Responsibilities

Provide clinical scientific leadership for the clinical development organization
Provide medical leadership for cross-functional internal workstreams including pharmacovigilance, biostatistics, clinical operations, regulatory affairs, etc
Provide medical safety oversight for Immunovant’s development programs
Collaborate with partners in the pharmacovigilance department in the analysis of clinical trial safety data
Collaborate closely with partners in Clinical Operations and be accountable for clinical trial conduct and timelines for associated key deliverables
Lead the design and writing of clinical protocols and associated clinical documents
Lead the writing of clinical and safety sections of key Program documents including Investigational New Drug submissions, Investigator Brochures, Clinical Study Reports, Development Safety Update Reports, Biologics License Applications, and other regulatory submissions and responses
Be responsible for the preparation, analysis, and presentation of safety data to internal and external safety monitoring boards
Assume primary responsibility for presentations related to clinical trial data and assist in the preparation of meeting abstracts, posters, and presentations related to clinical trial data
Contribute to the writing of manuscripts and publications
Comply with Immunovant’s SOPs and adhere to ICH, GCP, and relevant regulatory guidelines
Provide medical leadership for internal audits and regulatory inspections
Assist in preparation of materials for Advisory Board meetings, IMVT BOD meetings, etc
Develop and maintain strong, collaborative relationships with the broader Immunovant organization
Represent Immunovant externally and build successful relationships with multiple stakeholders including trial site Investigators, KOLs, and others

Qualification

Clinical trial designMedical oversightRegulatory submissionsImmunology experienceAnalytical skillsStrategic planningCross-functional collaborationTeamworkCommunication skillsAttention to detail

Required

Leadership experience in early to late-stage development in an industry (Biotech and/or Pharma) setting
Proven ability to plan and conduct clinical trials
Deliver high-quality results within established timelines
Demonstrated track record in working effectively in cross-functional teams and work streams (pharmacovigilance, biostatistics, clinical operations, and regulatory affairs)
Ability to thrive in a fast-paced environment
Excellence in verbal and written communication, teamwork, and collaboration is a must
Proven ability to successfully manage multiple tasks and prioritize accordingly
Attention to detail, internal drive to generate high-quality work, and sense of passion and urgency to achieve team and program goals
Excellent analytical, problem-solving, and strategic planning skills
Strong interpersonal skills commensurate with the need to work closely with CROs, investigators, consultants, and team members across functions
Exceptional written and oral communication skills to meet the needs of varied audiences
Integrated understanding of FDA, EMA, ICH, and GCP guidelines
MD, DO, or non-US equivalent of MD degree
Domestic or international travel is required (20%)

Preferred

Prior late phase clinical trial experience in immunology, autoimmune or other rare diseases within the immunology/inflammation space is desirable
Prior interactions with FDA and EMA regulatory agencies would be desirable

Company

Immunovant

twittertwitter
company-logo
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.

Funding

Current Stage
Public Company
Total Funding
$1.86B
Key Investors
Roivant Sciences
2025-12-11Post Ipo Equity· $550M
2025-01-13Post Ipo Equity· $450M
2023-09-27Post Ipo Equity· $450M

Leadership Team

leader-logo
Melanie Gloria
Chief Operating Officer
linkedin
Company data provided by crunchbase